| Year |
Citation |
Score |
| 2023 |
Mistry EA, Hart KW, Davis LT, Gao Y, Prestigiacomo CJ, Mittal S, Mehta T, LaFever H, Harker P, Wilson-Perez HE, Beasley KA, Krothapalli N, Lippincott E, Stefek H, Froehler M, ... ... Yeatts SD, et al. Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial. Jama. 330: 821-831. PMID 37668620 DOI: 10.1001/jama.2023.14330 |
0.348 |
|
| 2023 |
Zhao W, Yeatts SD, Broderick JP, Selim MH, Adeoye OM, Durkalski-Mauldin VL, Meinzer CN, Martin RH, Dillon CR, Cassarly CN, Pauls KH, Elm JJ. Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience. Stroke. PMID 37078281 DOI: 10.1161/STROKEAHA.122.040743 |
0.392 |
|
| 2022 |
Foster L, Robinson L, Yeatts SD, Conwit RA, Shehadah A, Lioutas V, Selim M. Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial. Stroke. STROKEAHA121037298. PMID 35306827 DOI: 10.1161/STROKEAHA.121.037298 |
0.367 |
|
| 2022 |
Mistry EA, Yeatts SD, Khatri P, Mistry AM, Detry M, Viele K, Harrell FE, Lewis RJ. National Institutes of Health Stroke Scale as an Outcome in Stroke Research: Value of ANCOVA Over Analyzing Change From Baseline. Stroke. STROKEAHA121034859. PMID 35012328 DOI: 10.1161/STROKEAHA.121.034859 |
0.404 |
|
| 2021 |
Mistry EA, Yeatts S, de Havenon A, Mehta T, Arora N, De Los Rios La Rosa F, Starosciak AK, Siegler JE, Mistry AM, Yaghi S, Khatri P. Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change. Stroke. STROKEAHA120032487. PMID 34000830 DOI: 10.1161/STROKEAHA.120.032487 |
0.336 |
|
| 2020 |
Yeatts SD, Martin RH, Meurer W, Silbergleit R, Rockswold G, Barsan WG, Korley FK, Wright D, Gajewski BJ. Sliding Scoring of the Glasgow Outcome Scale - Extended (GOS-E) as Primary Outcome in Traumatic Brain Injury Trials. Journal of Neurotrauma. PMID 32664792 DOI: 10.1089/Neu.2019.6969 |
0.336 |
|
| 2020 |
de Havenon A, Khatri P, Prabhakaran S, Yeatts SD, Peterson C, Sacchetti D, Alexander M, Cutting S, Grory BM, Furie K, Liebeskind DS, Yaghi S. Hypoperfusion Distal to Anterior Circulation Intracranial Atherosclerosis is Associated with Recurrent Stroke. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32579278 DOI: 10.1111/Jon.12710 |
0.421 |
|
| 2019 |
Chalos V, van der Ende NAM, Lingsma HF, Mulder MJHL, Venema E, Dijkland SA, Berkhemer OA, Yoo AJ, Broderick JP, Palesch YY, Yeatts SD, Roos YBWEM, van Oostenbrugge RJ, van Zwam WH, Majoie CBLM, et al. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. STROKEAHA119026791. PMID 31795895 DOI: 10.1161/Strokeaha.119.026791 |
0.512 |
|
| 2019 |
de Havenon A, Prabhakaran S, Turan T, Gottesman R, Yeatts S, Rost N. Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities? Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 104371. PMID 31495669 DOI: 10.1016/J.Jstrokecerebrovasdis.2019.104371 |
0.344 |
|
| 2019 |
Yaghi S, Khatri P, de Havenon A, Yeatts S, Chang AD, Cutting S, Mac Grory B, Burton T, Jayaraman MV, McTaggart RA, Fiorella D, Derdeyn C, Zaidat S, Dehkharghani S, Amin-Hanjani S, et al. Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis. Journal of Neurointerventional Surgery. PMID 31484697 DOI: 10.1136/Neurintsurg-2019-015225 |
0.426 |
|
| 2019 |
Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, Greenberg SM, James ML, Singh V, Clark WM, Norton C, Palesch YY, Yeatts SD. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. The Lancet. Neurology. PMID 30898550 DOI: 10.1016/S1474-4422(19)30069-9 |
0.316 |
|
| 2019 |
Frankel M, Fan L, Yeatts SD, Jeromin A, Vos PE, Wagner AK, Wolf BJ, Pauls Q, Lunney M, Merck LH, Hall CL, Palesch Y, Silbergleit R, David W. The Association of Very Early Serum levels of S100B, GFAP, UCH-L1, and SBDP with Outcome in ProTECT III. Journal of Neurotrauma. PMID 30794101 DOI: 10.1089/Neu.2018.5809 |
0.326 |
|
| 2019 |
Merck LH, Yeatts SD, Silbergleit R, Manley GT, Pauls Q, Palesch Y, Conwit R, Le Roux P, Miller J, Frankel M, Wright DW. The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury, Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial. Critical Care Medicine. PMID 30730438 DOI: 10.1097/Ccm.0000000000003680 |
0.307 |
|
| 2019 |
Lansberg MG, Mlynash M, Hamilton S, Yeatts SD, Christensen S, Kemp S, Lavori PW, Gutierrez SO, Broderick J, Heit J, Marks MP, Albers GW. Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial. Jama Neurology. PMID 30688974 DOI: 10.1001/Jamaneurol.2018.4587 |
0.519 |
|
| 2018 |
Bauza C, Martin R, Yeatts SD, Borg K, Magwood G, Selassie A, Ford ME. Determining the Joint Effect of Obesity and Diabetes on All-Cause Mortality and Cardiovascular-Related Mortality following an Ischemic Stroke. Stroke Research and Treatment. 2018: 4812712. PMID 30174819 DOI: 10.1155/2018/4812712 |
0.36 |
|
| 2018 |
Nichols C, Carrozzella J, Yeatts S, Tomsick T, Broderick J, Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? Journal of Neurointerventional Surgery. 10: i40-i43. PMID 30037954 DOI: 10.1136/jnis.2009.001768.rep |
0.375 |
|
| 2018 |
Khatri P, Kleindorfer DO, Devlin T, Sawyer RN, Starr M, Mejilla J, Broderick J, Chatterjee A, Jauch EC, Levine SR, Romano JG, Saver JL, Vagal A, Purdon B, Devenport J, ... ... Yeatts SD, et al. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. Jama. 320: 156-166. PMID 29998337 DOI: 10.1001/jama.2018.8496 |
0.407 |
|
| 2018 |
Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, Rasmussen PA, Zaidat OO, Broderick JP, Yeatts SD, Hamilton S, Mlynash M, Albers GW. Endovascular Treatment in the DEFUSE 3 Study. Stroke. PMID 29986935 DOI: 10.1161/Strokeaha.118.022147 |
0.423 |
|
| 2018 |
Bauza C, Yeatts SD, Borg K, Magwood G, Martin RH, Selassie A, Ford ME. Determining the joint effect of obesity and diabetes on functional disability at 3-months and on all-cause mortality at 1-year following an ischemic stroke. Bmc Endocrine Disorders. 18: 40. PMID 29914457 DOI: 10.1186/S12902-018-0255-1 |
0.408 |
|
| 2018 |
Yeatts SD, Broderick JP, Chatterjee A, Jauch EC, Levine SR, Romano JG, Saver JL, Vagal A, Purdon B, Devenport J, Khatri P. Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018765269. PMID 29570044 DOI: 10.1177/1747493018765269 |
0.494 |
|
| 2018 |
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. The New England Journal of Medicine. PMID 29364767 DOI: 10.1056/Nejmoa1713973 |
0.411 |
|
| 2018 |
Nuño T, Denninghoff KR, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley G, Wright DW. Reply to: Prehospital Intubation: Further Confounders in Trial Results. Prehospital Emergency Care : Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors. 1. PMID 29338483 DOI: 10.1080/10903127.2017.1408729 |
0.341 |
|
| 2017 |
Albers GW, Lansberg MG, Kemp S, Tsai JP, Lavori P, Christensen S, Mlynash M, Kim S, Hamilton S, Yeatts SD, Palesch Y, Bammer R, Broderick J, Marks MP. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). International Journal of Stroke : Official Journal of the International Stroke Society. 12: 896-905. PMID 28946832 DOI: 10.1177/1747493017701147 |
0.45 |
|
| 2017 |
Fan L, Yeatts SD, Foster LD, Khatri P, Tomsick T, Broderick JP, Palesch YY. Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale. Interventional Neurology. 6: 25-30. PMID 28611830 DOI: 10.1159/000452137 |
0.47 |
|
| 2017 |
Denninghoff KR, Nuño T, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley GT, Wright DW. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehospital Emergency Care : Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors. 1-6. PMID 28489506 DOI: 10.1080/10903127.2017.1315201 |
0.348 |
|
| 2017 |
Simpson KN, Simpson AN, Mauldin PD, Palesch YY, Yeatts SD, Kleindorfer D, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, et al. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. Journal of the American Heart Association. 6. PMID 28483774 DOI: 10.1161/Jaha.116.004513 |
0.464 |
|
| 2017 |
Venema E, Mulder MJHL, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P, Berkhemer OA, Emmer BJ, Roos YBWEM, Majoie CBLM, van Oostenbrugge RJ, van Zwam WH, van der Lugt A, Steyerberg EW, Dippel DWJ, et al. Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. Bmj (Clinical Research Ed.). 357: j1710. PMID 28468840 DOI: 10.1136/Bmj.J1710 |
0.489 |
|
| 2017 |
Mulder MJ, Venema E, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P, Berkhemer OA, Roos YB, Majoie CB, van Oostenbrugge RJ, van Zwam WH, van der Lugt A, Steyerberg EW, Dippel DW, Lingsma HF. Towards personalised intra-arterial treatment of patients with acute ischaemic stroke: a study protocol for development and validation of a clinical decision aid. Bmj Open. 7: e013699. PMID 28336740 DOI: 10.1136/Bmjopen-2016-013699 |
0.418 |
|
| 2016 |
Lansberg MG, Bhat NS, Yeatts SD, Palesch YY, Broderick JP, Albers GW, Lai TL, Lavori PW. Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke. 47: 2931-2937. PMID 27895297 DOI: 10.1161/Strokeaha.116.015436 |
0.478 |
|
| 2016 |
Schmitz ML, Yeatts SD, Tomsick TA, Liebeskind DS, Vagal A, Broderick JP, Khatri P. Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial. Interventional Neurology. 5: 118-122. PMID 27781039 DOI: 10.1159/000446749 |
0.484 |
|
| 2016 |
Tomsick TA, Carrozzella J, Foster L, Hill MD, von Kummer R, Goyal M, Demchuk AM, Khatri P, Palesch Y, Broderick JP, Yeatts SD, Liebeskind DS. Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes. Ajnr. American Journal of Neuroradiology. PMID 27765740 DOI: 10.3174/Ajnr.A4979 |
0.356 |
|
| 2016 |
Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke; a Journal of Cerebral Circulation. PMID 27462118 DOI: 10.1161/STROKEAHA.116.012825 |
0.415 |
|
| 2016 |
Vagal A, Foster LD, Menon B, Livorine A, Shi J, Qazi E, Yeatts SD, Demchuk AM, Hill MD, Tomsick TA, Goyal M. Multimodal CT Imaging: Time to Treatment and Outcomes in the IMS III Trial. Ajnr. American Journal of Neuroradiology. PMID 26988811 DOI: 10.3174/Ajnr.A4751 |
0.411 |
|
| 2016 |
Goldstein FC, Caveney A, Hertzberg VS, Silbergleit R, Yeatts S, Palesch Y, Levin H, David W. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe TBI. Journal of Neurotrauma. PMID 26973025 DOI: 10.1089/Neu.2015.4313 |
0.31 |
|
| 2016 |
Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, et al. Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology. PMID 26802090 DOI: 10.1212/Wnl.0000000000002399 |
0.38 |
|
| 2015 |
Vagal A, Menon BK, Foster LD, Livorine A, Yeatts SD, Qazi E, d'Esterre C, Shi J, Demchuk AM, Hill MD, Liebeskind DS, Tomsick T, Goyal M. Association Between CT Angiogram Collaterals and CT Perfusion in the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. PMID 26658448 DOI: 10.1161/Strokeaha.115.011461 |
0.398 |
|
| 2015 |
Tomsick TA, Foster LD, Liebeskind DS, Hill MD, Carrozella J, Goyal M, von Kummer R, Demchuk AM, Dzialowski I, Puetz V, Jovin T, Morales H, Palesch YY, Broderick J, Khatri P, ... Yeatts SD, et al. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. Ajnr. American Journal of Neuroradiology. 36: 2074-81. PMID 26228892 DOI: 10.3174/Ajnr.A4421 |
0.458 |
|
| 2015 |
Abou-Chebl A, Yeatts SD, Yan B, Cockroft K, Goyal M, Jovin T, Khatri P, Meyers P, Spilker J, Sugg R, Wartenberg KE, Tomsick T, Broderick J, Hill MD. Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of Interventional Management of Stroke (IMS) III Trial. Stroke; a Journal of Cerebral Circulation. PMID 26138125 DOI: 10.1161/STROKEAHA.115.008761 |
0.398 |
|
| 2015 |
Khatri P, Tayama D, Cohen G, Lindley RI, Wardlaw JM, Yeatts SD, Broderick JP, Sandercock P. Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis. Stroke; a Journal of Cerebral Circulation. PMID 26106113 DOI: 10.1161/Strokeaha.115.009951 |
0.481 |
|
| 2015 |
Yeatts SD, Martin RH. What is missing from my missing data plan? Stroke; a Journal of Cerebral Circulation. 46: e130-2. PMID 25953373 DOI: 10.1161/Strokeaha.115.007984 |
0.384 |
|
| 2015 |
Palesch YY, Yeatts SD, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, et al. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 46: 1321-7. PMID 25858239 DOI: 10.1161/Strokeaha.115.009180 |
0.487 |
|
| 2015 |
Menon BK, Qazi E, Nambiar V, Foster LD, Yeatts SD, Liebeskind D, Jovin TG, Goyal M, Hill MD, Tomsick TA, Broderick JP, Demchuk AM. Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 46: 1239-44. PMID 25791716 DOI: 10.1161/Strokeaha.115.009009 |
0.497 |
|
| 2015 |
Nicholas K, Yeatts SD, Zhao W, Ciolino J, Borg K, Durkalski V. The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials. Statistics in Medicine. 34: 1834-40. PMID 25641057 DOI: 10.1002/Sim.6447 |
0.31 |
|
| 2015 |
Zhao W, Mu Y, Tayama D, Yeatts SD. Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies. Contemporary Clinical Trials. 41: 211-8. PMID 25638754 DOI: 10.1016/J.Cct.2015.01.013 |
0.432 |
|
| 2015 |
Chiuzan C, Garrett-Mayer E, Yeatts SD. A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designs. Clinical Trials (London, England). 12: 24-33. PMID 25349178 DOI: 10.1177/1740774514555585 |
0.316 |
|
| 2014 |
Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG. Very early administration of progesterone for acute traumatic brain injury. The New England Journal of Medicine. 371: 2457-66. PMID 25493974 DOI: 10.1056/Nejmoa1404304 |
0.3 |
|
| 2014 |
Vagal AS, Khatri P, Broderick JP, Tomsick TA, Yeatts SD, Eckman MH. Time to angiographic reperfusion in acute ischemic stroke: decision analysis. Stroke; a Journal of Cerebral Circulation. 45: 3625-30. PMID 25352484 DOI: 10.1161/Strokeaha.114.007188 |
0.376 |
|
| 2014 |
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Mazighi M, Schonewille WJ, Engelter ST, et al. Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke; a Journal of Cerebral Circulation. 45: 3606-11. PMID 25325911 DOI: 10.1161/Strokeaha.114.005952 |
0.45 |
|
| 2014 |
Rahme R, Yeatts SD, Abruzzo TA, Jimenez L, Fan L, Tomsick TA, Ringer AJ, Furlan AJ, Broderick JP, Khatri P. Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. Journal of Neurosurgery. 121: 1354-8. PMID 25259569 DOI: 10.3171/2014.7.JNS131430 |
0.368 |
|
| 2014 |
Khatri P, Yeatts SD. Complexity of the endovascular intervention and clinical outcomes in acute ischaemic stroke--authors' reply. The Lancet. Neurology. 13: 865-6. PMID 25142454 DOI: 10.1016/S1474-4422(14)70175-9 |
0.455 |
|
| 2014 |
Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, Hill MD, Jovin TG, Ribo M, Yan B, Zaidat OO, Frei D, von Kummer R, Cockroft KM, Khatri P, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 273: 202-10. PMID 24895878 DOI: 10.1148/Radiol.14132649 |
0.377 |
|
| 2014 |
Simpson KN, Simpson AN, Mauldin PD, Hill MD, Yeatts SD, Spilker JA, Foster LD, Khatri P, Martin R, Jauch EC, Kleindorfer D, Palesch YY, Broderick JP. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 45: 1791-8. PMID 24876261 DOI: 10.1161/Strokeaha.113.003874 |
0.446 |
|
| 2014 |
Goyal M, Almekhlafi MA, Fan L, Menon BK, Demchuk AM, Yeatts SD, Hill MD, Tomsick T, Khatri P, Zaidat OO, Jauch EC, Eesa M, Jovin TG, Broderick JP. Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation. 130: 265-72. PMID 24815501 DOI: 10.1161/Circulationaha.113.007826 |
0.449 |
|
| 2014 |
Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, Amarenco P, Carrozzella J, Spilker J, Foster LD, Goyal M, Hill MD, Palesch YY, Jauch EC, Haley EC, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. The Lancet. Neurology. 13: 567-74. PMID 24784550 DOI: 10.1016/S1474-4422(14)70066-3 |
0.516 |
|
| 2014 |
Yeatts SD, Martin RH, Coffey CS, Lyden PD, Foster LD, Woolson RF, Broderick JP, Di Tullio MR, Jungreis CA, Palesch YY. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke; a Journal of Cerebral Circulation. 45: 1408-14. PMID 24699059 DOI: 10.1161/Strokeaha.113.003925 |
0.475 |
|
| 2014 |
Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, Jovin TG, Khatri P, von Kummer R, Sugg RM, Zaidat OO, Hussain SI, Goyal M, Menon BK, Al Ali F, et al. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke; a Journal of Cerebral Circulation. 45: 759-64. PMID 24473178 DOI: 10.1161/Strokeaha.113.004072 |
0.491 |
|
| 2014 |
Hill MD, Demchuk AM, Goyal M, Jovin TG, Foster LD, Tomsick TA, von Kummer R, Yeatts SD, Palesch YY, Broderick JP. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke; a Journal of Cerebral Circulation. 45: 444-9. PMID 24335227 DOI: 10.1161/Strokeaha.113.003580 |
0.4 |
|
| 2014 |
Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JL, Yeatts SD, et al. Designing clinical trials for dystonia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 117-27. PMID 24282121 DOI: 10.1007/S13311-013-0221-6 |
0.362 |
|
| 2013 |
Garofolo KM, Yeatts SD, Ramakrishnan V, Jauch EC, Johnston KC, Durkalski VL. The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes. Trials. 14: 98. PMID 24499406 DOI: 10.1186/1745-6215-14-98 |
0.487 |
|
| 2013 |
Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocritical Care. 19: 257-66. PMID 23943316 DOI: 10.1007/S12028-013-9861-Y |
0.362 |
|
| 2013 |
Yeatts SD. Novel methodologic approaches to phase I, II, and III trials. Stroke; a Journal of Cerebral Circulation. 44: S116-8. PMID 23709704 DOI: 10.1161/Strokeaha.111.000031 |
0.436 |
|
| 2013 |
Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, Labreuche J, Meseguer E, Yeatts SD, Siddiqui AH, Broderick J, Molina CA, Qureshi AI, Amarenco P. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation. 127: 1980-5. PMID 23671178 DOI: 10.1161/Circulationaha.112.000311 |
0.364 |
|
| 2013 |
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. The New England Journal of Medicine. 368: 893-903. PMID 23390923 DOI: 10.1056/Nejmoa1214300 |
0.371 |
|
| 2012 |
Yeatts SD, Gennings C, Crofton KM. Optimal design for the precise estimation of an interaction threshold: the impact of exposure to a mixture of 18 polyhalogenated aromatic hydrocarbons. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: 1784-97. PMID 22640366 DOI: 10.1111/J.1539-6924.2012.01834.X |
0.475 |
|
| 2011 |
Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, Schlaug G, Torbey M, Waldman B, Xi G, Palesch Y. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke; a Journal of Cerebral Circulation. 42: 3067-74. PMID 21868742 DOI: 10.1161/Strokeaha.111.617589 |
0.358 |
|
| 2011 |
Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, Yeatts SD, Tamariz D, Ryckborst K. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke; a Journal of Cerebral Circulation. 42: 119-27. PMID 21164127 DOI: 10.1161/Strokeaha.110.596072 |
0.454 |
|
| 2010 |
Yeatts SD, Gennings C, Wagner ED, Simmons JE, Plewa MJ. Detecting Departure From Additivity Along a Fixed-Ratio Mixture Ray With a Piecewise Model for Dose and Interaction Thresholds. Journal of Agricultural, Biological, and Environmental Statistics. 15: 510-522. PMID 21359103 DOI: 10.1007/S13253-010-0030-X |
0.464 |
|
| 2010 |
Khatri P, Kleindorfer DO, Yeatts SD, Saver JL, Levine SR, Lyden PD, Moomaw CJ, Palesch YY, Jauch EC, Broderick JP. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke; a Journal of Cerebral Circulation. 41: 2581-6. PMID 20814000 DOI: 10.1161/Strokeaha.110.593632 |
0.474 |
|
| 2010 |
Nichols C, Carrozzella J, Yeatts S, Tomsick T, Broderick J, Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? Journal of Neurointerventional Surgery. 2: 67-70. PMID 20431708 DOI: 10.1136/Jnis.2009.001768 |
0.487 |
|
| 2009 |
Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 73: 1066-72. PMID 19786699 DOI: 10.1212/Wnl.0B013E3181B9C847 |
0.46 |
|
| 2007 |
Kennedy RE, Yeatts SD, Archer KJ, Gennings C, Ramakrishnan V. Opportunities for biostatistics students: Training and fellowship grants from the National Institutes of Health American Statistician. 61: 120-126. DOI: 10.1198/000313007X188342 |
0.436 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Fan L, Yeatts SD, Wolf BJ, McClure LA, Selim M, Palesch YY. The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization. Statistical Methods in Medical Research. PMID 26596352 DOI: 10.1177/0962280215616405 |
0.29 |
|
| 2018 |
Yaghi S, Khatri P, Prabhakaran S, Yeatts SD, Cutting S, Jayaraman M, Chang AD, Sacchetti D, Liebeskind DS, Furie KL. What Threshold Defines Penumbral Brain Tissue in Patients with Symptomatic Anterior Circulation Intracranial Stenosis: An Exploratory Analysis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30398302 DOI: 10.1111/Jon.12577 |
0.287 |
|
| 2014 |
Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, von Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, et al. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. Journal of Neurointerventional Surgery. PMID 25342652 DOI: 10.1136/Neurintsurg-2014-011318 |
0.277 |
|
| 2021 |
Wei C, Wang J, Foster LD, Yeatts SD, Moy C, Mocco J, Selim M. Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial. Stroke. STROKEAHA121035421. PMID 34789008 DOI: 10.1161/STROKEAHA.121.035421 |
0.265 |
|
| 2023 |
Harder TJ, Leary OP, Yang Z, Lucke-Wold B, Liu DD, Still MEH, Zhang M, Yeatts SD, Allen JW, Wright D, Merck D, Merck LH. Early Signs of Elevated Intracranial Pressure (ICP) on Computed Tomography Correlate with Measured ICP in the Intensive Care Unit and Six-Month Outcome Following Moderate to Severe TBI. Journal of Neurotrauma. PMID 37082956 DOI: 10.1089/neu.2022.0433 |
0.244 |
|
| 2019 |
Yaghi S, Grory BM, Prabhakaran S, Yeatts SD, Cutting S, Jayaraman M, Sacchetti D, Furie K, Zaidat OO, Liebeskind DS, Khatri P. Infarct Pattern, Perfusion Mismatch Thresholds, and Recurrent Cerebrovascular Events in Symptomatic Intracranial Stenosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 31112323 DOI: 10.1111/Jon.12630 |
0.239 |
|
| 2023 |
Wang Y, Yeatts SD, Martin RH, Silbergleit R, Rockswold GL, Barsan WG, Korley FK, Rockswold S, Gajewski BJ. Selection of a statistical analysis method for the Glasgow Outcome Scale-Extended endpoint for estimating the probability of favorable outcome in future severe TBI clinical trials. Statistics in Medicine. PMID 37599009 DOI: 10.1002/sim.9877 |
0.235 |
|
| 2013 |
Saladin ME, Gray KM, McRae-Clark AL, Larowe SD, Yeatts SD, Baker NL, Hartwell KJ, Brady KT. A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans. Psychopharmacology. 226: 721-37. PMID 23460266 DOI: 10.1007/S00213-013-3039-3 |
0.234 |
|
| 2022 |
Bantis LE, Young KJ, Tsimikas JV, Mosier BR, Gajewski B, Yeatts S, Martin RL, Barsan W, Silbergleit R, Rockswold G, Korley FK. Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies. Research Methods in Medicine & Health Sciences. 4: 34-48. PMID 37009524 DOI: 10.1177/26320843221141056 |
0.222 |
|
| 2022 |
Yeatts SD, Foster LD, Barsan WG, Berry NS, Callaway CW, Lewis RJ, Saville BR, Silbergleit R, Kline JA. An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism. Clinical Trials (London, England). 17407745221105897. PMID 35786002 DOI: 10.1177/17407745221105897 |
0.218 |
|
| 2017 |
Ellis M, Pauls Q, Yeatts S, Wright D, Mika V, Welch R. 282 Optimizing Enrollment Strategies for Traumatic Brain Injury Clinical Trials: A Secondary Analysis of the ProTECT III Trial Annals of Emergency Medicine. 70: S111. DOI: 10.1016/J.Annemergmed.2017.07.260 |
0.21 |
|
| 2011 |
Argraves KM, Sethi AA, Gazzolo PJ, Wilkerson BA, Remaley AT, Tybjaerg-Hansen A, Nordestgaard BG, Yeatts SD, Nicholas KS, Barth JL, Argraves WS. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids in Health and Disease. 10: 70. PMID 21554699 DOI: 10.1186/1476-511X-10-70 |
0.208 |
|
| 2008 |
Back SE, Brady KT, Waldrop AE, Yeatts SD, McRae AL, Spratt E. Early life trauma and sensitivity to current life stressors in individuals with and without cocaine dependence. The American Journal of Drug and Alcohol Abuse. 34: 389-96. PMID 18584568 DOI: 10.1080/00952990802122614 |
0.208 |
|
| 2008 |
Back SE, Waldrop AE, Saladin ME, Yeatts SD, Simpson A, McRae AL, Upadhyaya HP, Contini Sisson R, Spratt EG, Allen J, Kreek MJ, Brady KT. Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology. 33: 560-8. PMID 18321653 DOI: 10.1016/J.Psyneuen.2008.01.012 |
0.201 |
|
| 2019 |
Yeatts SD, Mlynash M, Lavori PW, Albers GW, Lansberg MG, Broderick JP, Palesch YY, Hamilton S. Abstract TP43: Evaluating the Generalizability of the Common Odds Ratio: A Demonstration using Two Trials of Endovascular Therapy Stroke. 50. DOI: 10.1161/str.50.suppl_1.tp43 |
0.197 |
|
| 2020 |
Korley FK, Pauls Q, Yeatts SD, Jones C, Corbett-Valade E, Silbergleit R, Frankel M, Barsan WG, Cahill N, Bazarian J, Wright D. Progesterone treatment does not decrease serum levels of biomarkers of glial and neuronal cell injury in moderate and severe TBI subjects: A secondary analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III trial. Journal of Neurotrauma. PMID 33319651 DOI: 10.1089/neu.2020.7072 |
0.187 |
|
| 2009 |
Spratt EG, Back SE, Yeatts SD, Simpson AN, McRae-Clark A, Moran-Santa Maria MM, Price KL, Hartwell KT, Brady KT. Relationship between child abuse and adult smoking. International Journal of Psychiatry in Medicine. 39: 417-26. PMID 20391862 DOI: 10.2190/Pm.39.4.F |
0.184 |
|
| 2021 |
Sheibani N, Wong KH, Turan TN, Yeatts SD, Gottesman RF, Prabhakaran S, Rost NS, de Havenon A. White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 30: 105764. PMID 33823461 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105764 |
0.18 |
|
| 2020 |
Leary OP, Merck LH, Yeatts SD, Pan I, Liu DD, Harder TJ, Jung S, Collins S, Braileanu M, Gokaslan ZL, Allen JW, Wright D, Merck D. Computer-Assisted Measurement of Traumatic Brain Hemorrhage Volume is More Predictive of Functional Outcome and Mortality than Standard ABC/2 Method: An Analysis of CT Imaging Data from the ProTECTIII Trial. Journal of Neurotrauma. PMID 33191851 DOI: 10.1089/neu.2020.7209 |
0.18 |
|
| 2022 |
Mainali S, Cardim D, Sarwal A, Merck LH, Yeatts SD, Czosnyka M, Shutter L. Prolonged Automated Robotic TCD Monitoring in Acute Severe TBI: Study Design and Rationale. Neurocritical Care. PMID 35381966 DOI: 10.1007/s12028-022-01483-6 |
0.166 |
|
| 2021 |
Greige T, Norton C, Foster LD, Yeatts SD, Thornhill A, Griffin J, Wang J, Hrdlicka CM, Selim M. Why Are Women Less Represented in Intracerebral Hemorrhage Trials? Stroke. 52: 442-446. PMID 33493043 DOI: 10.1161/STROKEAHA.120.032166 |
0.155 |
|
| 2016 |
Janardhan V, Yoo AJ, Shaltoni H, Abou-Chebl A, Chen PR, Britz GW, Novakovic R, Nanda A, Kaushal R, Issa MA, Frankel MR, Gupta R, Rai AT, Froehler MT, Badruddin A, ... ... Yeatts SD, et al. Contents Vol. 5, 2016 Interventional Neurology. 5. DOI: 10.1159/000449523 |
0.144 |
|
| 2023 |
McDyer JF, Azimpouran M, Durkalski-Mauldin VL, Clevenger RG, Yeatts SD, Deng X, Barsan W, Silbergleit R, El Kassar N, Popescu I, Dimitrov D, Li W, Lyons EJ, Lieber SC, Stone M, et al. COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response. Jci Insight. PMID 36862515 DOI: 10.1172/jci.insight.167890 |
0.127 |
|
| 2019 |
Yaghi S, Khatri P, Prabakharan S, Yeatts S, Cutting S, Jayaraman M, McTaggart R, Chang A, Sacchetti D, Liebeskind D, Furie K. Abstract WP86: What Threshold Defines Penumbral Brain Tissue in Patients With Symptomatic Anterior Circulation Intracranial Stenosis: An Exploratory Analysis Stroke. 50. DOI: 10.1161/Str.50.Suppl_1.Wp86 |
0.114 |
|
| 2022 |
Bernard F, Barsan W, Diaz-Arrastia R, Merck LH, Yeatts S, Shutter LA. Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure alone. Bmj Open. 12: e060188. PMID 35273066 DOI: 10.1136/bmjopen-2021-060188 |
0.109 |
|
| 2022 |
Muehlschlegel S, Perman SM, Elmer J, Haggins A, Teixeira Bailey ND, Huang J, Jansky L, Kirchner J, Kasperek-Wynn R, Lipman PD, Yeatts SD, Fetters MD, Dickert NW, Silbergleit R. The Experiences and Needs of Families of Comatose Patients After Cardiac Arrest and Severe Neurotrauma: The Perspectives of National Key Stakeholders During a National Institutes of Health-Funded Workshop. Critical Care Explorations. 4: e0648. PMID 35265851 DOI: 10.1097/CCE.0000000000000648 |
0.094 |
|
| 2023 |
Cummins MR, Burr J, Young L, Yeatts SD, Ecklund DJ, Bunnell BE, Dwyer JP, VanBuren JM. Decentralized research technology use in multicenter clinical research studies based at U.S. academic research centers. Journal of Clinical and Translational Science. 7: e250. PMID 38229901 DOI: 10.1017/cts.2023.678 |
0.065 |
|
| 2021 |
Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, El Kassar N, Foster LD, Hah JM, Jaiswal S, Kaplan A, Lowell E, McDyer JF, Quinn J, Triulzi DJ, et al. Early Convalescent Plasma for High-Risk Outpatients with Covid-19. The New England Journal of Medicine. PMID 34407339 DOI: 10.1056/NEJMoa2103784 |
0.061 |
|
| 2022 |
de Havenon A, Sheth KN, Yeatts SD, Turan TN, Prabhakaran S. White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment. Stroke and Vascular Neurology. PMID 35487617 DOI: 10.1136/svn-2021-001357 |
0.056 |
|
| 2015 |
Wright DW, Yeatts SD, Silbergleit R. Progesterone in traumatic brain injury. The New England Journal of Medicine. 372: 1766-7. PMID 25923558 DOI: 10.1056/NEJMc1503138 |
0.053 |
|
| 2007 |
Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, Markowitz JS. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clinical Pharmacology and Therapeutics. 81: 346-53. PMID 17339864 DOI: 10.1038/sj.clpt.6100082 |
0.053 |
|
| 2014 |
Rahme R, Yeatts SD, Abruzzo TA, Jimenez L, Fan L, Tomsick TA, Ringer AJ, Furlan AJ, Broderick JP, Khatri P. Response. Journal of Neurosurgery. 121: 1352-3. PMID 25584368 |
0.021 |
|
| Hide low-probability matches. |